Signum Morning Briefing 29 May

Sign up for the event: “Vaccines, prevention, and their commercial implications for Nordic pharma“

Hundreds of vaccine candidates are in development globally. That’s not just a pipeline number. It signals a shift in how resources get allocated, how market access works, and how the pharmaceutical industry partners with healthcare systems.

At this Signum Morning Briefing, we’ll zoom in on how the prevention and vaccination paradigm is changing the playing field for market access, policy, commercial models, organization, and collaboration between the pharmaceutical industry and the healthcare sector in Denmark, the Nordic region, and globally.

What we’ll cover

• Where Danish vaccine policy stands and where it’s heading
• What prevention looks like on the ground with a former WHO expert

Is this event for you?

The event is for all commercial pharma professionals who want to understand what the prevention-versus-treatment shift means for their brands and their plans. You don’t need to work directly with vaccines to get value out of this event.

• Lif’s perspectives and recommendations for strengthening future vaccination efforts (Tyge Arnold Canto Larsen, Chief Consultant, Policy & Analysis at Lif).
• Sharp insights from a vaccine expert with WHO experience (Tine Rikke Jørgensen, Chief Consultant, Value & Access at Signum).

N.B. The event is in English, but you’re welcome to ask questions in Danish. See the complete program below*.